Risk factors

GoPro faces substantial operating losses, including a $135.0 million loss in 2024 driven by delayed product launches and macroeconomic conditions.

Low margins and inflation dominate product costs and operational profitability. Reliance on third-party suppliers creates supply chain vulnerability. Material weaknesses in internal controls threaten reliable financial reporting. Significant insider ownership creates potential shareholder conflicts.

Customer concentration is high, with our largest client representing 11.9% of total accounts receivable in 2024. Contact center and B2B engagements are typically cancellable on short notice by clients. We rely on data suppliers, leasehold properties, and third-party telecommunications infrastructure for core operations.

Health In Tech relies on a network of brokers and TPAs across 41 states to drive its self-insurance platforms. The company faces concentrated risks from AI adoption, underwriting algorithm errors, and key leadership under CEO Tim Johnson. Public company compliance and a dual-class structure create additional governance and market volatility exposures.

Hallador Energy's risks are dominated by customer concentration at the Merom plant, strict credit and covenant terms under its credit agreement, and intense regulatory and ESG pressures on its fossil fuel operations.

Credit losses, asset quality, liquidity, and interest-rate changes are central risks for this Missouri and eastern Kansas community bank.

Hyperfine relies entirely on commercializing its Swoop portable MRI system and single manufacturer Benchmark.

Clinical-stage biotechnology company with no product revenue, relying entirely on external financing and collaborations for drug development.

Identiv's risk profile centers on its post-Asset Sale transition into an IoT and RFID pure-play company. Heavy customer concentration, manufacturing dependency in Asia, and intense competition shape its operational hurdles.

Real estate market dependency and geographic concentration in North Carolina and Texas dominate the company risk profile. Extensive federal and state regulatory compliance burdens and cybersecurity threats significantly impact operations. Reliance on independent agents and financial institution deposits presents notable operational vulnerabilities.

Kingsway Corp faces heavy reliance on debt servicing, acquisition integration, and niche markets like healthcare staffing and warranty services.

Roxadustat and FG-3246 drive our business value and commercial success. Drug development faces extensive regulatory review and intense competition globally. Third-party manufacturers and collaborators are critical to our supply chain and clinical success.